12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaNov 19 16:05 ET

Alumis Inc.: Promising Clinical Advancements and Strategic Positioning Drive Buy Rating

TipRanksNov 19 01:45 ET · Ratings

Alumis Presents Data Highlighting ESK-001's Potential as a High-efficacy Oral Treatment for Systemic Lupus Erythematosus (SLE) at ACR Convergence 2024

GlobeNewswireNov 14 16:05 ET

Express News | Cantor Fitzgerald Reiterates Overweight on Alumis

BenzingaNov 14 08:56 ET

Alumis Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 14 06:24 ET · Ratings

Express News | Alumis Inc. : H.c. Wainwright Cuts Target Price to $26 From $30

ReutersNov 14 06:11 ET